Acyclic and Cyclic Amine Derivatives

Details for Australian Patent Application No. 2005202769 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Mullican, Michael D.; Tung, Roger; Lauffer, David J.

Agent Cullen & Co

Pub. Number AU-A-2005202769

Parent 64972

Filing date 24 June 2005

Wipo publication date 21 July 2005

International Classifications

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

C07D 211/32 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/06 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 207/06 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/44 - Non-condensed pyridines

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 038/18 Medicinal preparations containing peptides - Growth factors

Event Publications

7 July 2005 Complete Application Filed

21 July 2005 Application Open to Public Inspection

  Published as AU-A-2005202769

9 February 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202770-Stabilization of fresh mozzarella cheese using fermented whey

2005202768-Transgenic Mammals Having Human IG LOCI Including Plural Vh and Vk Regions and Antibodies Produced Therefrom